Article Information
PubMed
Print ISSN
Online ISSN
History
- Received August 12, 2007
- Accepted April 16, 2008
- Published online June 19, 2008.
Article Versions
- Earlier version (April 17, 2008 - 08:20).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Lisa J. Christopher,
- Donghui Cui1,
- Chiyuan Wu,
- Roger Luo,
- James A. Manning,
- Samuel J. Bonacorsi,
- Michael Lago,
- Alban Allentoff,
- Francis Y. F. Lee,
- Betty McCann,
- Susan Galbraith,
- Donald P. Reitberg,
- Kan He,
- Anthony Barros, Jr.,
- Anne Blackwood-Chirchir2,
- W. Griffith Humphreys and
- Ramaswamy A. Iyer
- Departments of Pharmaceutical Candidate Optimization (L.J.C., D.C., J.A.M., K.H., A.B., W.G.H., R.A.I.), Discovery Medicine and Clinical Pharmacology (C.W., R.L., B.M., S.G., D.P.R., A.B.-C.), Chemical Synthesis (S.J.B., M.L., A.A.), and Discovery Biology (F.Y.F.L.), Bristol-Myers Pharmaceutical Research and Development, Princeton, New Jersey
- Address correspondence to:
Ramaswamy A. Iyer, Department of Biotransformation, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Mail Stop F13-08, Princeton, NJ 08540. E-mail: ramaswamy.iyer{at}bms.com
Statistics from Altmetric.com
Article usage
In this issue
Metabolism and Disposition of Dasatinib after Oral Administration to Humans
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement